Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Medtech Insight and Windhover Information's 2007 ''Investment in Innovation (In3) East''

Abstract:


More Than 50 Companies to Present New Technologies Seeking Funding, Strategic Partnerships

October 3-5, 2007

Westin Copley Place, Boston, MA

Medtech Insight and Windhover Information's 2007 ''Investment in Innovation (In3) East''

NORWALK, CT | Posted on August 29th, 2007

-Forty-seven companies have already signed up to present their technologies at the Investment in Innovation (In3) East partnering event this October, to an audience of company presidents; CEOs; chairmen; venture partners; managing directors; vice presidents/directors of business development, marketing, new technology, acquisitions, R&D and sales; and senior investment analysts/managers/directors.

In3 East, sponsored by Medtech Insight, a division of Windhover Information, is the largest East Coast strategic partnership and investment meeting for medical technology executives.

More than 50 companies with exciting new technologies will present, seeking funding and/or strategic partnership. These companies will provide 10-minute overviews by a senior executive from each company, followed by the opportunity to meet one-on-one in private breakout rooms. Presenting companies represent a vast range of technologies, including cardiovascular/interventional cardiology, diagnostics, drug delivery, imaging, minimally invasive surgery, nanotechnology, neurostimulation, orthopedics/spine, peripheral vascular, stem cells, stroke management, wound management and much more.

All In3 East presenters have been selected for this event by an advisory board of top medical technology venture capitalists, to ensure a high-quality slate of technologies.

A complete list of all presenting companies to date is available at http://www.windhover.com/mti/spk .

Guidant's Ronald Dollens to Be Keynote Speaker

Also offered at In3 East are keynote presentations and on-stage interviews with industry leaders; investment and financing panel discussions by prominent device industry executives; venture capital dealmaking presentations; buy side panels; and educational workshops for start-up companies.

The event will be highlighted by a keynote address by Ronald W. Dollens, retired president & CEO of Guidant Corp. Dollens' topic will be Leadership at Medical Device Companies: Achieving the Performance and Payout you Want. Over a legendary career that saw the company that would become Guidant grow from a small manufacturer of angioplasty devices into a global leader in cardiovascular devices, Dollens built one of the great medical device companies of all times. And his exit was as amazing as his beginnings: The acquisition of Guidant by Boston Scientific was, by far, the largest deal the device industry had ever seen — a true testimony to the prominence that Guidant, and Dollens, had achieved over the years.

In his keynote address, Dollens will discuss his career and the lessons he's learned, and offers guidance to device company executives about building a global device giant.

Other speakers and panelists include Christopher Velis, Chairman & CEO, Medical Capital Advisors; Jonathan Silverstein, General Partner, OrbiMed Advisors LLC; Rob Adelman MD, Private Equity Partner, Orbimed; and Thomas Pollare, Partner, 3i. Panel discussions include From Board Room to Court Room: How Well-Intended But Misguided Judgments and Decisions Can Derail A Promising Company; and Anatomy of a Financing: A Panel with VCs and Their Portfolio Companies on How Deals Get Done.

A Must-Attend Event for Thousands of Executives

Windhover's conferences have drawn over 6,100 attendees and 700 innovative early-stage presenting companies over the past six years, making them the premier investment, partnering, and networking events in the medical technology industry. Among the 113 companies already registered to attend are Boston Scientific Corp., DePuy Spine Inc., Edwards Angell Palmer & Dodge LLP, Guidant, NeoMed Technologies Inc., Pinnacle Ventures LLC, Stryker and many more.

For more information, to register for this event, and to see a complete agenda and list of attending companies, visit http://www.medtechinsight.com .

This year's co-sponsors include 3i; AdvaMed; Battelle; CCI International; Medical Capital Advisors; Medmarc® and The Hartford, Edwards, Angell, Palmer & Dodge; Ronald Trahan Associates; The MedTech Group Inc.; and Underwriters Laboratories Inc.

Financial contributor is the Telemedicine & Advanced Technology Research Center (TATRC).

Media sponsors are Business Wire; the Medical Device Manufacturers Association; and The Journal of Biolaw & Business.

To attend this conference, you may register online at http://www.medtechinsight.com , or call 1-949-219-0150 or 888-290-2225 (toll-free in the U.S.), or e-mail .

####

About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace.

For more information, please click here

Contacts:
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes, 480-985-9512
Or 888-202-5939 toll-free in the U.S.

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Events/Classes

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project